The wealth management firm stated that Indian equities could be 'hurt' by the global 'risk-off' sentiment among investors.

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical data and approvals approach.

One of the most successful investors of all time dropped some wisdom.

First-year GM Jon-Eric Sullivan has taken a thoughtful yet surprisingly aggressive approach to Miami Dolphins free agency. It's quite a start.

You may be waiting for bracket advice, but the 2026 NCAA Tournament will not wait for you to finish flipping a coin sweating ...

Rezolve AI stock might be one of the most compelling small-cap companies, and Wall Street isn't paying attention to it.

In this week’s edition of our power rankings, we see the Dallas Stars take the No. 1 spot, while several middle-of-the-pack ...

The iShares Morningstar Small-Cap Value ETF (NYSEMKT:ISCV) charges a much lower expense ratio and offers a higher dividend yield than the iShares Russell 2000 Value ETF (NYSEMKT:IWN). IWN delivered a ...

After several years of market leadership by speculative growth stocks, early signals suggest the balance may be shifting ...

Explore how differences in sector balance, yield, and risk profile set these two small-cap growth ETFs apart for investors.

The first week of NFL free agency is in the books, and while many of the biggest names have already been signed, several ...

That's the message from many analysts, including a team of strategists at Goldman Sachs led by Ben Snider. In a note published late Friday, the Goldman team acknowledge growing risks that ...